Home › Companies › KODIAK SCIENCES INC. › 2024-2025

KODIAK SCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and KODIAK SCIENCES INC.’s Form 8-K, filed 2025-06-03 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 6Reported items
  • 123Asset managers
  • 629Fund votes
  • 2025-06-02Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore KODIAK SCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by KODIAK SCIENCES INC.

These tallies are KODIAK SCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-03 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

KODIAK SCIENCES INC. — official shareholder meeting results, meeting held 2025-06-02
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Richard S. Levy, M.D. 29,171,558---- 8,444,5755,754,783 Majority: yes
Elect Director: Robert A. Profusek, J.D. 24,691,172---- 12,924,9615,754,783 Majority: yes
Proposal Two – Advisory Approval of the Compensation of Named Executive Officers . The compensation of the Company's named executive officers was approved, on an advisory basis, by the stockholders. 35,200,8642,365,79649,473 --5,754,783 Majority: yes

Source: KODIAK SCIENCES INC., Form 8-K, filed with the SEC on 2025-06-03 — read the filing on EDGAR.

How asset managers voted at the KODIAK SCIENCES INC. 2024-2025 meeting

Each item below shows how the 123 asset managers that disclosed a KODIAK SCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of KODIAK SCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 35,200,864AGAINST: 2,365,796

KODIAK SCIENCES INC.’s own tally for this item (“Proposal Two – Advisory Approval of the Compensation of Named Executive Officers . The compensation of the Company's named executive officers was approved, on an advisory basis, by the stockholders.”): 35,200,864 for, 2,365,796 against, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,751,875 outstanding shares: 67% for, 4% against (71% of the company cast a for/against vote).

The 121 asset managers below cast 94% of the shares they voted on this item FOR (32,965,006 for, 2,194,534 against).

FOR 94%
FOR: 32,965,006 (93.8%)AGAINST: 2,194,534 (6.2%)
Largest asset managers voting on “Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the prox” at KODIAK SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BAKER BROS. ADVISORS LP17,310,4900 00For
BlackRock2,728,982241 00For
Vanguard1,722,7670 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.1,325,7070 00For
ICONIQ Capital, LLC01,266,563 00Against
Fidelity1,166,5150 00For
TCG Crossover Management, LLC1,145,5380 00For
Point721,018,1340 00For
GEODE CAPITAL MANAGEMENT, LLC791,7570 00For
State Street737,6300 00For
Charles Schwab526,6080 00For
JACOBS LEVY EQUITY MANAGEMENT, INC476,0190 00For
DE Shaw461,7480 00For
Nantahala Capital Management, LLC445,2640 00For
Dimensional0408,960 00Against
Federated Hermes0376,597 00Against
BRUCE FUND INC323,0000 00For
Northern Trust300,5870 00For
SILVERARC CAPITAL MANAGEMENT, LLC292,8150 00For
Renaissance197,3480 00For
American Century151,2680 00For
Nuveen139,6880 00For
TIAA135,9190 00For
Goldman Sachs130,8660 00For
Equitable127,1240 00For

Showing the 25 largest of 121 asset managers. See all 121 in the interactive database.

2. Elect two Class I directors nominated by our board and named in this proxy statement: Richard S. Levy, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%WITHHELD 22%
FOR: 29,171,558WITHHELD: 8,444,575

KODIAK SCIENCES INC.’s own tally for this item (“Elect Director: Richard S. Levy, M.D.”): 29,171,558 for, 8,444,575 withheld, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,751,875 outstanding shares: 55% for, 16% withheld (71% of the company cast a for/withheld vote).

The 46 asset managers below cast 100% of the shares they voted on this item FOR (4,577,404 for, 0 against).

FOR 75%ABSTAIN 25%
FOR: 4,577,404 (74.8%)ABSTAIN: 1,540,828 (25.2%)
Largest asset managers voting on “Elect two Class I directors nominated by our board and named in this proxy statement: Richard S. Levy, M.D.” at KODIAK SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,667,8990 17,5980For
BlackRock836,3670 529,2240For
Fidelity927,7370 9,1380For
BRUCE FUND INC323,0000 00For
Dimensional00 272,8680Abstain
Charles Schwab263,3040 00For
Federated Hermes188,1840 00For
TIAA00 135,9190Abstain
Equitable60,5140 66,6100Abstain
Goldman Sachs00 125,0290Abstain
Columbia Threadneedle98,1620 00For
BRIDGEWAY FUNDS INC00 94,2000Abstain
American Century00 75,6340Abstain
Nationwide7,7830 58,3240Abstain
QUANTITATIVE MASTER SERIES LLC54,2970 00For
Northern Trust44,2180 00For
GuideStone00 34,3220Abstain
Lincoln Financial23,3150 1,1550For
Global X19,2780 00For
Pacific Life18,3600 00For
AIG/SunAmerica00 15,9840Abstain
Meeder Funds00 15,1370Abstain
Bridge Builder Trust15,0590 00For
John Hancock00 13,5610Abstain
Jackson National00 13,2400Abstain

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

3. Elect two Class I directors nominated by our board and named in this proxy statement: Robert A. Profusek, J.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

66% Majority: yes · of votes cast

FOR 66%WITHHELD 34%
FOR: 24,691,172WITHHELD: 12,924,961

KODIAK SCIENCES INC.’s own tally for this item (“Elect Director: Robert A. Profusek, J.D.”): 24,691,172 for, 12,924,961 withheld, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,751,875 outstanding shares: 46.8% for, 25% withheld (71% of the company cast a for/withheld vote).

The 46 asset managers below cast 100% of the shares they voted on this item FOR (3,186,889 for, 0 against).

FOR 52.1%ABSTAIN 47.9%
FOR: 3,186,889 (52.1%)ABSTAIN: 2,931,343 (47.9%)
Largest asset managers voting on “Elect two Class I directors nominated by our board and named in this proxy statement: Robert A. Profusek, J.D.” at KODIAK SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,667,8990 17,5980For
BlackRock00 1,365,5910Abstain
Fidelity927,7370 9,1380For
BRUCE FUND INC323,0000 00For
Dimensional00 272,8680Abstain
Charles Schwab263,3040 00For
Federated Hermes00 188,1840Abstain
TIAA00 135,9190Abstain
Equitable00 127,1240Abstain
Goldman Sachs00 125,0290Abstain
Columbia Threadneedle00 98,1620Abstain
BRIDGEWAY FUNDS INC00 94,2000Abstain
American Century00 75,6340Abstain
Nationwide2,3210 63,7860Abstain
QUANTITATIVE MASTER SERIES LLC00 54,2970Abstain
Northern Trust00 44,2180Abstain
GuideStone00 34,3220Abstain
Lincoln Financial00 24,4700Abstain
Global X00 19,2780Abstain
Pacific Life00 18,3600Abstain
AIG/SunAmerica00 15,9840Abstain
Meeder Funds00 15,1370Abstain
Bridge Builder Trust00 15,0590Abstain
John Hancock00 13,5610Abstain
Jackson National00 13,2400Abstain

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

4. Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 44 asset managers below cast 99.9% of the shares they voted on this item FOR (6,074,717 for, 133 against).

FOR: 6,074,717 (100.0%)AGAINST: 133 (0.0%)
Largest asset managers voting on “Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for ” at KODIAK SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,685,4970 00For
BlackRock1,365,5910 00For
Fidelity936,8750 00For
BRUCE FUND INC323,0000 00For
Dimensional272,8680 00For
Charles Schwab263,3040 00For
Federated Hermes188,1840 00For
TIAA135,9190 00For
Equitable127,1240 00For
Goldman Sachs125,0290 00For
Columbia Threadneedle98,1620 00For
BRIDGEWAY FUNDS INC94,2000 00For
American Century75,6340 00For
Nationwide66,1070 00For
QUANTITATIVE MASTER SERIES LLC54,2970 00For
Northern Trust44,2180 00For
Lincoln Financial24,4700 00For
Global X19,2780 00For
Pacific Life18,3600 00For
AIG/SunAmerica15,9840 00For
Meeder Funds15,1370 00For
Bridge Builder Trust15,0590 00For
John Hancock13,5610 00For
Jackson National13,2400 00For
MASTER INVESTMENT PORTFOLIO12,7270 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

5. Ratify PricewaterhouseCoopers LLP as Auditors

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (43,382 for, 0 against).

FOR: 43,382 (100.0%)
Largest asset managers voting on “Ratify PricewaterhouseCoopers LLP as Auditors” at KODIAK SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
GuideStone34,3220 00For
HC CAPITAL TRUST9,0600 00For

6. Say on pay

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

94% Majority: yes · of votes cast

FOR 94%
FOR: 35,200,864AGAINST: 2,365,796

KODIAK SCIENCES INC.’s own tally for this item (“Proposal Two – Advisory Approval of the Compensation of Named Executive Officers . The compensation of the Company's named executive officers was approved, on an advisory basis, by the stockholders.”): 35,200,864 for, 2,365,796 against, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,751,875 outstanding shares: 67% for, 4% against (71% of the company cast a for/against vote).

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 95 against).

AGAINST 100%
AGAINST: 95 (100.0%)
Largest asset managers voting on “Say on pay” at KODIAK SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Empower095 00Against
Ikarian Capital, LLC00 00--

Largest KODIAK SCIENCES INC. shareholders voting in 2024-2025

Ranked by the number of KODIAK SCIENCES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 52,751,875 shares outstanding at the time of that meeting.

Top KODIAK SCIENCES INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1BAKER BROS. ADVISORS LP 32.81%
2BlackRock 5.17%
3Vanguard 3.27%
4ADAGE CAPITAL PARTNERS GP, L.L.C. 2.51%
5ICONIQ Capital, LLC 2.40%
6Fidelity 2.21%
7TCG Crossover Management, LLC 2.17%
8Point72 1.93%
9GEODE CAPITAL MANAGEMENT, LLC 1.50%
10State Street 1.40%

Reported KODIAK SCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

KODIAK SCIENCES INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Felix J. Baker, Ph.D. 33.02% DEF14A
Entities affiliated with Baker Bros. Advisors LP 32.81% DEF14A
Victor Perlroth, M.D. 15.81% DEF14A
D. VICTOR PERLROTH, M.D. 12.33% 13G
Entities affiliated with BlackRock, Inc. 7.64% DEF14A
BlackRock 7.07% 13F
Vanguard Group 3.20% 13F
John A. Borgeson 2.16% DEF14A
Point72 2.03% 13F
State Street 1.61% 13F

Percentages above are of 52,751,875 shares outstanding, as reported by KODIAK SCIENCES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KODIAK SCIENCES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At KODIAK SCIENCES INC.'s shareholder meeting held 2025-06-02, in the 2024-2025 proxy season, 123 asset managers reported how they voted in their SEC Form N-PX filings, covering 629 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as… — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: KODIAK SCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-03.

KODIAK SCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.